These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 4975396

  • 1. Inhibition of melanin formation by sulfhydryl compounds.
    Seiji M, Yoshida T, Itakura H, Irimajiri T.
    J Invest Dermatol; 1969 Mar; 52(3):280-6. PubMed ID: 4975396
    [No Abstract] [Full Text] [Related]

  • 2. Effect of thiol compounds on melanin formation by tyrosinase.
    Sanada H, Suzue R, Nakashima Y, Kawada S.
    Biochim Biophys Acta; 1972 Jan 28; 261(1):258-66. PubMed ID: 4622270
    [No Abstract] [Full Text] [Related]

  • 3. The role of peroxidase vs. the role of tyrosinase in enzymatic conversion of tyrosine to melanin in melanocytes, mast cells and eosinophils.
    Okun MR, Edelstein LM, Or N, Hamada G, Donnellan B.
    J Invest Dermatol; 1970 Jul 28; 55(1):1-12. PubMed ID: 4987505
    [No Abstract] [Full Text] [Related]

  • 4. [On the biosynthesis and structure of animal melanin. In vivo studies with tritium and 14C-labelled dopa on the mouse Harding-Passey melanoma].
    Hempel K.
    Z Naturforsch B; 1967 Feb 28; 22(2):173-80. PubMed ID: 4384714
    [No Abstract] [Full Text] [Related]

  • 5. Incorporation of sulfhydryl compounds into melanins in vitro.
    Ito S, Imai Y, Jimbow K, Fujita K.
    Biochim Biophys Acta; 1988 Jan 12; 964(1):1-7. PubMed ID: 3120789
    [Abstract] [Full Text] [Related]

  • 6. FUNCTION-SPECIFIC CHANGES IN THE METABOLISM OF AGOUTI PIGMENT CELLS.
    CLEFFMANN G.
    Exp Cell Res; 1964 Sep 12; 35():590-600. PubMed ID: 14208746
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of tyrosinase-catalyzed melanin formation by catechol phenyl sulfones.
    Siuda JF, Habal A.
    J Med Chem; 1974 Nov 12; 17(11):1173-7. PubMed ID: 4213190
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Synthesis of noradrenaline from 3,4-dihydroxyphenylalanine (DOPA) and dopamine in adrenergic nerves of mouse atrium--effect of reserpine, monoamine oxidase and tyrosine hydroxylase inhibition.
    Jonsson G, Sachs C.
    Acta Physiol Scand; 1970 Nov 12; 80(3):307-22. PubMed ID: 5486459
    [No Abstract] [Full Text] [Related]

  • 14. Stimulation of DOPA14C incorporation into melanoma tissue by chlorpromazine and reserpine.
    Saunders RN, Miya TS, Bousquet WF.
    Toxicol Appl Pharmacol; 1970 Mar 12; 16(2):434-41. PubMed ID: 4985146
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Melanin synthesis in tissue cultures of melanoma in mice].
    Oikawa A.
    Saishin Igaku; 1968 Mar 10; 23(3):597-605. PubMed ID: 4971778
    [No Abstract] [Full Text] [Related]

  • 18. Isolation and partial characterization of the natural inhibitor of dopa autoxidation in skin.
    Flawn PC, Wilde PF.
    J Invest Dermatol; 1970 Sep 10; 55(3):153-8. PubMed ID: 4990027
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. ON THE SITE OF MELANIN FORMATION IN MELANOCYTES.
    SEIJI M, IWASHITA S.
    J Biochem; 1963 Nov 10; 54():465-7. PubMed ID: 14089743
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.